Brought to you by 
UK biotech Pharmagene raises $56mm in IPO
30 Aug 2000
Executive Summary
British biotech company Pharmagene raised about $56mm (£37mm) in its IPO of 17.79mm new and existing ordinary shares priced at $4.32 (£2.85) per share. The offering was four times oversubscribed.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
UK biotech Pharmagene raises $56mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice